EDGAR Verified
Primary Source · SEC.gov

RiverRock Longevity Fund I LP

CIK 0001976637Fund Vehicle2023 vintage506(b), 3(c)(1)

Raised

Pre-open

Investors

Min Invest

$5,000,000

AltStreet Analysis

·

Generated from EDGAR primary sources

RiverRock Longevity Fund I LP is a Cayman Islands-domiciled pooled investment fund focusing on longevity biotech, filed May 30, 2023, as an original pre-open offering under Rule 506(b) and Section 3(c)(1). Capital raised and investor count have not been disclosed; the minimum investment is $5.0M. The fund is managed by RiverRock Longevity Fund I GP, LLC with Anthony Annino and Valerie Coffey as executive officers.

This longevity biotech fund employs a standard 506(b)/3(c)(1) private fund exemption structure with a $5.0M minimum investment, placing it in the institutional/high-net-worth tier typical of specialized life sciences vehicles. The offshore Cayman domicile is common for funds targeting international LPs or requiring flexible tax and regulatory treatment in biotech venture strategies.

Data Flags

generalOffshore domicile (Cayman Islands) filing Form D indicates cross-border fund structure
total_amount_soldPre-open filing with no disclosed first sale date or capital raised; typical for institutional fund launch but limits transparency at this stage

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001976637
Entity NameRiverRock Longevity Fund I LP
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateMay 30, 2023
Accession Number0001976637-23-000002
Total Amount Sold
Total Investors
Minimum Investment$5,000,000
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

- RiverRock Longevity Fund I GP, LLC

Promoter · Austin, TX

Anthony Annino

Executive Officer, Director · Austin, TX

Valerie Coffey

Executive Officer · Austin, TX

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.